Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users.
about
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studiesMortality by causes in HIV-infected adults: comparison with the general population.Some aspects of the natural history of HIV infection.Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.HIV infection and risk of overdose: a systematic review and meta-analysisPrevalence and correlates of opiate overdose among young injection drug users in a large U.S. cityAntiretroviral HIV treatment and care for injecting drug users: an evidence-based overviewThe role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations.Aging and HIV infectionImportance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients.Social and structural factors associated with HIV disease progression among illicit drug users: a systematic reviewThe shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.HIV treatment as prevention among people who inject drugs - a re-evaluation of the evidence.Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort Study.HIV transmission and the cost-effectiveness of methadone maintenance.
P2860
Q24656950-D5083CD7-5125-457A-A704-1A18CCAA79F9Q33898621-18895537-A0B2-4360-BE0C-E59E591BEA31Q34018002-D795ED7A-C712-4A51-94C2-0E1A435CE04AQ35413625-17AE3992-C2B3-4D0E-97AA-EA75523F712AQ35622250-4B4465C8-AAFA-407C-A3A5-5F2B8C9901A7Q35834104-8EEBB65C-F59E-4327-8301-EAA0FDC0DCEEQ35898498-22FE0759-EE32-44D0-90A0-2C0FFF70ADA4Q35946118-53558BC2-6824-41F7-A17B-FA2BECC70267Q36063045-232A0D03-1D2C-43E4-A95E-A68BEBEA7822Q36249104-ED2ABC11-BE58-4D5D-9F7D-9508ECE5E7B8Q36482458-B15D6AC9-61FD-4CAC-82E5-9DD4C8CA32E1Q36943004-0B8B2881-3FD4-4378-9CF1-F3F14E6812BEQ37638817-85E7FFF9-568D-40A2-9BE9-E12EFF19C75FQ38457525-59A45721-E401-4465-9A01-1EA9FC72A371Q39727219-043F9B14-3FD4-4503-8FC5-F89A59F88759Q40622144-F76C3662-56EA-4046-850E-830392F306B7Q50141101-3363EFC1-1866-4F2A-BF5B-14AB395465B2Q52278638-24D50474-559C-4B7B-B459-19267BB4718A
P2860
Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Pre-AIDS mortality from natura ...... dy among injecting drug users.
@en
type
label
Pre-AIDS mortality from natura ...... dy among injecting drug users.
@en
prefLabel
Pre-AIDS mortality from natura ...... dy among injecting drug users.
@en
P2093
P1433
P1476
Pre-AIDS mortality from natura ...... dy among injecting drug users.
@en
P2093
Brettle RP
Coutinho RA
Goldberg DJ
Hernández Aguado IH
Robertson JR
Zangerle R
van den Hoek A
P304
P356
10.1097/00002030-199714000-00012
P407
P577
1997-11-01T00:00:00Z